中文产业新闻精选评分61Chinese source
BMS肺纤维化新药Admilparant三期临床获顶线结果，主打安全性优势
特发性肺纤维化治疗三期成功！BMS肺纤维化新药Admilparant三期临床获顶线结果，最大亮点是安全性，千万患者迎来曙光
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
特发性肺纤维化治疗三期成功！BMS肺纤维化新药Admilparant三期临床获顶线结果，最大亮点是安全性，千万患者迎来曙光
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.